A quick and easy test to detect cancer from blood or biopsy tissue could eventually result in a new approach to patient diagnosis.
The test has been developed by University of Queensland researchers Dr Abu Sina, Dr Laura Carrascosa and Professor Matt Trau, who have discovered a unique DNA nanostructure that appears to be common to all cancers.
Cancer is an extremely complicated and variable disease and different types of cancer have different signatures.
Dr Sina said it had been difficult to find a simple signature that was distinct from healthy cells and common to all cancers.
“This unique nano-scaled DNA signature appeared in every type of breast cancer we examined, and in other forms of cancer including prostate, colorectal and lymphoma,” he said.
“The levels and patterns of tiny molecules called methyl groups that decorate DNA are altered dramatically by cancer – these methyl groups are key for cells to control which genes are turned on and off.”
Dr Carrascosa said we took a holistic approach and developed a tool that could look at these pattern changes at the whole genome level within minutes.
“In healthy cells, these methyl groups are spread out across the genome, but the genomes of cancer cells are essentially barren except for intense clusters of methyl groups at very specific locations.”
Professor Trau said the team discovered that intense clusters of methyl groups placed in a solution caused cancer DNA fragments to fold into unique three-dimensional nanostructures that could easily be separated by sticking to solid surfaces such as gold.
“We designed a simple test using gold nanoparticles that instantly change colour to determine if the 3D nanostructures of cancer DNA are present,” Professor Trau said.
He said cancer cells released their DNA into blood plasma when they died.
“So we were very excited about an easy way of catching these circulating free cancer DNA signatures in blood,” he said.
“Discovering that cancerous DNA molecules formed entirely different 3D nanostructures from normal circulating DNA was a breakthrough that has enabled an entirely new approach to detect cancer non-invasively in any tissue type including blood.
“This led to the creation of inexpensive and portable detection devices that could eventually be used as a diagnostic tool, possibly with a mobile phone.”
The new technology has proved to be up to 90 percent accurate in tests involving 200 human cancer samples and normal DNA.
“We certainly don’t know yet whether it’s the holy grail for all cancer diagnostics, but it looks really interesting as an incredibly simple universal marker of cancer, and as an accessible and inexpensive technology that doesn’t require complicated lab-based equipment like DNA sequencing,” Professor Trau said.
The Latest on: Cancer diagnosis
via Google News
The Latest on: Cancer diagnosis
- COVID-19-related disruptions to cervical cancer screening could increase risk sevenfold, UK case study findson December 2, 2020 at 12:49 pm
A new study reveals inequalities in the delay in screening for cervical cancer, and recommends that the screening capacity be increased in addition to giving a higher priority to women who have missed ...
- Q&A: Y-90 therapy offers many benefits in treatment of liver canceron December 2, 2020 at 12:46 pm
My father has had chronic liver disease. Recently, he was diagnosed with liver cancer. His doctor mentioned Y-90 as one treatment option. What is Y-90, and is it safe?
- Bluestar Genomics, UChicago publish whole genome map of key biomarker for detecting canceron December 2, 2020 at 11:57 am
Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to cancer detection, and University of Chicago today announce the publication of a genome-wide ...
- Clinical Challenges: Can MRI and Biomarkers Replace Biopsy for AS in Prostate Cancer?on December 2, 2020 at 11:32 am
Can active surveillance of prostate cancer be conducted without biopsies? While patients on active surveillance undergo periodic prostate-specific antigen (PSA) and tumor burden assessments, which ...
- Digital pathology: Proscia raises $23 million for cancer diagnosis tech; AdaptHealth in $2 billion dealon December 1, 2020 at 11:21 am
Proscia, a six-year-old Center City-based startup which says its cancer-finding Concentriq software is used by 3,000 pathologists and scientists, has raised another $23 million from investors led by ...
- Anne Nolan reveals her breast cancer has 'disappeared' after undergoing chemotherapy treatmenton December 1, 2020 at 3:58 am
The former singer, 69, was diagnosed with breast cancer in June alongside younger sister Linda, who is battling secondary cancer and has also received chemotherapy treatment.
- Cancer survivors at higher risk of hospitalization or dying from fluon December 1, 2020 at 12:38 am
Survivors from a wide range of cancers are more likely than people in the general population to be hospitalised or die from seasonal influenza even several years after their cancer diagnosis, ...
- New DNA scanning method could lead to quicker diagnosis of cancer and rare diseaseon November 30, 2020 at 9:29 am
Understanding the sequence of human DNA gives scientists information about diseases, including potentially how to diagnose or treat them. In a new paper published in Nature Biotechnology, scientists ...
- What coverage does Medicare provide for liver cancer?on November 30, 2020 at 6:04 am
Medicare usually covers a person's diagnostic tests and treatment for liver cancer. Some out-of-pocket costs may apply. Read more here.
via Bing News